|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01548 GENSCRIPT BIO
Nominal 
10.940 +0.240 (+2.243%) | 2024/06 - Interim USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | 2020/12 USD(K$) | |
| Net Cash from / (used in) Operating Activities | -- | (286,911) | (120,292) | (136,790) | (151,093) |
| Net Cash from / (used in) Investing Activities | -- | (357,728) | (443,296) | (212,548) | (100,166) |
| Net Cash from / (used in) Financing Activities | -- | 1,068,260 | 419,317 | 902,141 | 624,203 |
| Increase / (Decrease) in Cash & Cash Equivalents | -- | 423,621 | (144,271) | 552,803 | 372,944 |
| Cash & Cash Equivalents at beginning of period | -- | 1,023,999 | 1,180,971 | 629,058 | 252,397 |
| Effect of Foreign Exchange Rate Changes | -- | (1,217) | (12,701) | (890) | 3,717 |
| Others | -- | 0 | 0 | 0 | 0 |
| Cash & Cash Equivalents at end of period | -- | 1,446,403 | 1,023,999 | 1,180,971 | 629,058 |
| Remarks: | Real time quote last updated: 03/12/2024 13:17 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders ($) | USD -175,115,000 |
| %Change | 87.127% |
| EPS / (LPS) | USD -0.083 |
| NBV Per Share ($) | USD 0.571 |